MedCity News

Wilson Sonsini tops Life Sciences Law Stiff Index for 2nd straight year

Cellular therapy just got real: Novartis is the very first to get FDA approval for CAR-T treatment (Updated)

At $475,000, the therapy isn’t cheap but for its part, Novartis has said patients would only pay the total whack if they react to the therapy by the end of the very first month. Continue reading →